Laval, Canada

Moulay Alaoui-Jamali

This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Mcgill University, Osta Biotechnologies, Queen's University at Kingston. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Moulay Alaoui-Jamali. Retrieved from https://idiyas.com/inventor/moulay-alaoui-jamali

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 42.9

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Laval, CA (2002 - 2013)
  • Outremont, CA (2015 - 2024)

Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Moulay Alaoui-Jamali

Introduction

Moulay Alaoui-Jamali is a notable inventor based in Laval, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. With a total of 7 patents, his work focuses on the creation of compounds that have the potential to treat various forms of cancer and neurodegenerative disorders.

Latest Patents

One of his latest patents involves substituted imidazole derivatives and methods of use for treating cancer. This patent discloses compounds of a general formula that can be used in compositions to treat or prevent cancer and inhibit tumor tissue growth. These compounds are designed to attenuate oxidative damage associated with increased heme-oxygenase activity and can reduce cell proliferation in transformed cells. Additionally, the described compounds and compositions serve as neuroprotectants and are useful for treating or preventing neurodegenerative disorders and other diseases of the central nervous system. Another significant patent outlines methods of treating cancer with imidazolyl compounds, specifically targeting prostate cancer, ovarian cancer, melanoma, colorectal cancer, breast cancer, and lung cancer.

Career Highlights

Throughout his career, Moulay Alaoui-Jamali has worked with various organizations, including Osta Biotechnologies and Queen's University at Kingston. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Moulay has collaborated with notable individuals such as Ajay Gupta and Hyman M Schipper. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Moulay Alaoui-Jamali's innovative work in the field of cancer treatment showcases his dedication to improving healthcare through scientific research. His patents reflect a commitment to developing effective therapies that can significantly impact patients' lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…